We are live on ! Find out more
GC

Grimes & Company Portfolio holdings

AUM $4.62B
1-Year Est. Return 29.71%
This Fund
S&P 500
This Quarter Est. Return
+3.74%
1 Year Est. Return
+29.71%
3 Year Est. Return
+66.17%
5 Year Est. Return
+73.59%
10 Year Est. Return
+287.63%
AUM
$2.82B
AUM Growth
+$380M
Cap. Flow
+$289M
Cap. Flow %
10.23%
Top 10 Hldgs %
47.61%
Holding
326
New
24
Increased
122
Reduced
122
Closed
11

Sector Composition

Rank Sector Weight
1 Technology 12.49%
2 Healthcare 6.65%
3 Financials 4.76%
4 Industrials 4.1%
5 Consumer Discretionary 2.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CARR icon
201
Carrier Global
CARR
$50.6B
$531K 0.02%
10,689
+43
+0.4% +$1.89K
CHKP icon
202
Check Point Software Technologies
CHKP
$13.1B
$530K 0.02%
4,216
GPC icon
203
Genuine Parts
GPC
$17.2B
$524K 0.02%
3,099
+9
+0.3% +$1.47K
T icon
204
AT&T
T
$159B
$523K 0.02%
32,804
-2,643
-7% -$45K
BCRX icon
205
BioCryst Pharmaceuticals
BCRX
$2.35B
$512K 0.02%
72,672
+350
+0.5% +$2.81K
OEF icon
206
iShares S&P 100 ETF
OEF
$19.9B
$511K 0.02%
2,470
ES icon
207
Eversource Energy
ES
$27.8B
$503K 0.02%
7,090
-3,164
-31% -$236K
VRIG icon
208
Invesco Variable Rate Investment Grade ETF
VRIG
$1.8B
$499K 0.02%
20,043
KRE icon
209
State Street SPDR S&P Regional Banking ETF
KRE
$4.49B
$490K 0.02%
12,011
-400
-3% -$16.4K
MFC icon
210
Manulife Financial
MFC
$74B
$483K 0.02%
25,552
ED icon
211
Consolidated Edison
ED
$40.4B
$471K 0.02%
5,214
+4
+0.1% +$382
OTIS icon
212
Otis Worldwide
OTIS
$27.3B
$465K 0.02%
5,226
+2
+0% +$168
SHEL icon
213
Shell
SHEL
$250B
$458K 0.02%
7,592
+8
+0.1% +$480
D icon
214
Dominion Energy
D
$61.3B
$458K 0.02%
8,837
-190
-2% -$10.3K
MPC icon
215
Marathon Petroleum
MPC
$91.7B
$454K 0.02%
3,890
-212
-5% -$24.6K
AFL icon
216
Aflac
AFL
$64.8B
$448K 0.02%
6,421
BSX icon
217
Boston Scientific
BSX
$68.4B
$438K 0.02%
8,102
-2
-0% -$104
IRWD icon
218
Ironwood Pharmaceuticals
IRWD
$614M
$426K 0.02%
40,051
MCHP icon
219
Microchip Technology
MCHP
$40.7B
$424K 0.02%
4,729
TRV icon
220
Travelers Companies
TRV
$78.4B
$410K 0.01%
2,361
-7
-0.3% -$1.24K
AZN icon
221
AstraZeneca
AZN
$266B
$410K 0.01%
2,864
-93
-3% -$13.7K
ALE
222
DELISTED
Allete
ALE
$398K 0.01%
6,867
HDSN
223
Hudson Technologies
HDSN
$244M
$396K 0.01%
41,163
YUM icon
224
Yum! Brands
YUM
$43.3B
$392K 0.01%
2,831
+16
+0.6% +$2.17K
MRNS
225
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$377K 0.01%
34,751

Similar funds

Grimes & Company's Q2 2023 Portfolio in Review

As of Q2 2023, Grimes & Company held 326 positions worth $2.82B, up 16% from $2.44B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Grimes & Company deployed $289M of net new capital in Q2 2023, opening 24 new positions and adding to 122 existing holdings. Its largest new stake was LHA Risk-Managed Income ETF: 1,188,814 shares worth $29.9M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street Communication Services Select Sector SPDR ETF, an estimated $21.8M trimmed.

  • Grimes & Company's largest Q2 2023 buy was LHA Risk-Managed Income ETF: 1,188,814 shares worth $29.9M.
  • Grimes & Company added most to iShares Russell 2000 ETF in Q2 2023, an estimated $160M increase.
  • Grimes & Company's biggest Q2 2023 reduction was State Street Communication Services Select Sector SPDR ETF, cutting an estimated $21.8M.
  • Grimes & Company fully exited State Street Materials Select Sector SPDR ETF in Q2 2023, selling an estimated $17M.
  • Grimes & Company's ten largest holdings make up 48% of its $2.82B portfolio in Q2 2023.
  • Grimes & Company opened 24 new positions and closed 11 in Q2 2023.
  • Grimes & Company's portfolio value rose 16% quarter-over-quarter to $2.82B.

Based on Grimes & Company's 13F filing for Q2 2023, filed 19 Jul 2023.